TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 255 filers reported holding TG THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $38,449,215 | -5.0% | 1,547,875 | -42.5% | 0.07% | -24.7% |
Q1 2023 | $40,456,442 | +12.3% | 2,689,923 | -11.6% | 0.09% | -36.0% |
Q4 2022 | $36,015,453 | +270.3% | 3,044,417 | +85.3% | 0.14% | +348.4% |
Q3 2022 | $9,725,000 | +29.5% | 1,642,675 | -7.0% | 0.03% | +55.0% |
Q2 2022 | $7,511,000 | -56.1% | 1,767,130 | -1.7% | 0.02% | -41.2% |
Q1 2022 | $17,099,000 | -51.8% | 1,798,010 | -3.8% | 0.03% | -48.5% |
Q4 2021 | $35,498,000 | -73.8% | 1,868,301 | -54.1% | 0.07% | -71.2% |
Q3 2021 | $135,393,000 | -14.5% | 4,068,301 | -0.3% | 0.23% | -2.1% |
Q2 2021 | $158,360,000 | -19.7% | 4,082,495 | -0.2% | 0.23% | -20.1% |
Q1 2021 | $197,171,000 | -7.1% | 4,090,691 | +0.3% | 0.29% | -15.1% |
Q4 2020 | $212,146,000 | +185.7% | 4,078,158 | +47.0% | 0.34% | +151.8% |
Q3 2020 | $74,259,000 | +68.3% | 2,775,000 | +22.5% | 0.14% | +22.3% |
Q2 2020 | $44,122,000 | +186.5% | 2,265,000 | +44.7% | 0.11% | +69.7% |
Q1 2020 | $15,400,000 | +38.7% | 1,565,000 | +56.5% | 0.07% | +61.0% |
Q4 2019 | $11,100,000 | – | 1,000,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |